Abbonarsi

RAndomized Cluster Evaluation of Cardiac ARrest Systems (RACE-CARS) trial: Study rationale and design - 05/09/24

Doi : 10.1016/j.ahj.2024.07.013 
Konstantin A. Krychtiuk, MD, PhD a, Monique A. Starks, MD, MHS a, Hussein R. Al-Khalidi, PhD a, Daniel B. Mark, MD, MPH a, Lisa Monk, MSN, RN, CPHQ a, Eric Yow, MS a, Lisa Kaltenbach, MS a, James G. Jollis, MD b, Sana M. Al-Khatib, MD, MHS a, Hayden B. Bosworth, PhD a, c, d, Kimberly Ward, MPH a, Sarah Brady, BS a, Clark Tyson a, Steve Vandeventer, EMT-P a, Khaula Baloch, MPH a, Megan Oakes, MS a, Audrey L. Blewer, PhD, MPH d, e, Allison A. Lewinski, PhD, MPH, RN c, d, Carolina Malta Hansen, MD, PhD f, g, h, Edward Sharpe b, Thomas D. Rea, MD, MPH i, R. Darrell Nelson, MD j, Comilla Sasson, MD, PhD k, Bryan McNally, MD, MPH l, Christopher B. Granger, MD a,
for the

RACE-CARS NC Counties

a Duke Clinical Research Institute, Durham, NC 
b Duke University, Durham, NC 
c Center of Innovation to Accelerate Discovery and Practice Transformation, Durham VA Health Care System, Durham, NC 
d Departments of Population Health Sciences, Medicine, Psychiatry, Nursing, Duke University Medical Center, Durham, NC 
e Department of Family Medicine and Community Health, Duke University School of Medicine, Durham, NC 
f Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark 
g Rigshospitalet, University of Copenhagen, Copenhagen, Denmark 
h Department of Clinical Medicine, Copenhagen Emergency Medical Services, University of Copenhagen, Copenhagen, Denmark 
i Department of Medicine, School of Medicine, University of Washington, Seattle, WA 
j Department of Emergency Medicine, Wake Forest School of Medicine, Winston-Salem, NC 
k Department of Psychiatry, and the Department of Community and Behavioral Health, Colorado School of Public Health, Aurora and the American Heart Association, University of Colorado School of Medicine, Dallas, TX 
l Emory University Rollins School of Public Health and Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA 

Reprint requests: Christopher B. Granger, MD, Duke Clinical Research Institute, 300 W Morgan Street, Durham, NC, 27701.Duke Clinical Research Institute300 W Morgan StreetDurhamNC27701.

ABSTRACT

Out-of-hospital cardiac arrest (OHCA) occurs in nearly 350,000 people each year in the United States (US). Despite advances in pre and in-hospital care, OHCA survival remains low and is highly variable across systems and regions. The critical barrier to improving cardiac arrest outcomes is not a lack of knowledge about effective interventions, but rather the widespread lack of systems of care to deliver interventions known to be successful. The RAndomized Cluster Evaluation of Cardiac ARrest Systems (RACE-CARS) trial is a 7-year pragmatic, cluster-randomized trial of 62 counties (57 clusters) in North Carolina using an established registry and is testing whether implementation of a customized set of strategically targeted community-based interventions improves survival to hospital discharge with good neurologic function in OHCA relative to control/standard care. The multifaceted intervention comprises rapid cardiac arrest recognition and systematic bystander CPR instructions by 9-1-1 telecommunicators, comprehensive community CPR training and enhanced early automated external defibrillator (AED) use prior to emergency medical systems (EMS) arrival. Approximately 20,000 patients are expected to be enrolled in the RACE CARS Trial over 4 years of the assessment period. The primary endpoint is survival to hospital discharge with good neurologic outcome defined as a cerebral performance category (CPC) of 1 or 2. Secondary outcomes include the rate of bystander CPR, defibrillation prior to arrival of EMS, and quality of life. We aim to identify successful community- and systems-based strategies to improve outcomes of OHCA using a cluster randomized-controlled trial design that aims to provide a high level of evidence for future application.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 Gregory Lip, MD served as Guest Editor for this manuscript.
 ClinicalTrials.gov Identifier: NCT04660526
 Trial Website: racecarstrial.org/
 The content of this article does not necessarily represent the view of the National Heart, Lung, and Blood Institute or the Department of Health and Human Services.


© 2024  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 277

P. 125-137 - novembre 2024 Ritorno al numero
Articolo precedente Articolo precedente
  • A randomized comparison of the treatment sequence of percutaneous coronary intervention and transcatheter aortic valve implantation: Rationale and design of the TAVI PCI trial
  • Barbara E. Stähli, Axel Linke, Dirk Westermann, Nicolas M. Van Mieghem, David M. Leistner, Steffen Massberg, Hannes Alber, Andreas Mügge, Giuseppe Musumeci, Rahel Kesterke, Steffen Schneider, Adnan Kastrati, Ian Ford, Frank Ruschitzka, Markus A. Kasel, TAVI PCI Investigators, Barbara E. Stähli, Markus Kasel, Frank Ruschitzka, Axel Linke, Nicolas Van Mieghem, Steffen Massberg, Dirk Westermann, Hannes Alber, Andreas Mügge, David M. Leistner, Giuseppe Musumeci, Steffen Schneider, Adnan Kastrati, Ian Ford, Stefano Savonitto, Bernhard Witzenbichler, Martin Swaans, Karl Swedberg, Stuart Pocock, Aldo Maggioni
| Articolo seguente Articolo seguente
  • Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design
  • Sneha S. Jain, Kenneth W. Mahaffey, Karen S. Pieper, Wataru Shimizu, Tatjana Potpara, Christian T. Ruff, Hooman Kamel, Basil S. Lewis, Jan H. Cornel, Peter R. Kowey, Jay Horrow, John Strony, Alexei N. Plotnikov, Danshi Li, Stephen Weng, Julia Donahue, C. Michael Gibson, P. Gabriel Steg, Roxana Mehran, Jeffrey I. Weitz, S. Claiborne Johnston, Graeme J. Hankey, Robert A. Harrington, Carolyn S.P. Lam, LIBREXIA AF Trial Investigators and Committees

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.